Endocrine Flashcards
Diabetes screening
Begins at age 45 every 3 years, annually if risk factors present
Lifestyle management of impaired fasting glucose
Lifestyle management, consider Metformin for co-morbids
Suggested A1C for most adults
< 7%
Suggested A1C for healthy older adults
< 7.5 %
Suggested A1C for older adults with co-morbids
< 8.0-8.5%
Suggested A1C for type 1 diabetics and most pregnant patients
< 6%
A1C testing frequency
Every three months if not in control, twice annually if in control
Name the sulfonylureas
Glimepiride, Glipizide, Glyburide “meds that end in ide”
DPP-4 inhibitors
Think meds that end in “ptin” such as sitagliptin
SGLT2’s
Think meds that end in “flozin” examples are Invokana and Jardiance
GLP-1’s
Think meds that end in “tide”
First line mediation for diabetes
Metformin
Labs to check before giving Metformin
LFT’s, kidney function
Second line for diabetes
SGL2’s or GLP-1’s (great choices for patients with cardiovascular disease)
Metformin dose is based on what?
GFR
Dual therapy should be considered in patients with what A1C?
A1C > 9%
Best initial dose of basal insulin
10 units
Adjustment recommendation
2-4 units 1-2 weekly until BGL goal is achieved
Levothyroxine is dosed based of what?
Ideal body weight, not actual body weight
When to treat subclinical hypothyroidism
Only if TSH is > 10
After levothyroxine is started, TSH is checked how often?
4-6 weeks until normal, then monitor annually unless symptoms
Dawn effect
BGL rises throughout night, caused by increase in growth hormone
What anemia is Metformin associated with
B12 anemia
Max dose of Metformin
2550 mg per day
